Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (08HH.SG)

1,5510 0,0000 (0,00%) Alla chiusura: 10:30AM CEST

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Building A
Fosun Technology Park No. 1289 Yishan Road
Shanghai 200233
China
86 21 3398 7000
https://www.fosunpharma.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 40.370

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Kexin Wang	Executive Co-Chairman	1,96M	N/D	1965
Mr. Yifang Wu	Executive Chairman	1,56M	N/D	1969
Mr. Deyong Wen	Joint President,CEO & Executive Director	1,28M	N/D	1971
Ms. Xiaohui Guan	Executive Vice Chairman	1,17M	N/D	1971
Mr. Shengli Li	Executive President & Chief Growth Officer	N/D	N/D	1974
Ms. Rongli Feng	Executive President, Chief Human Resources Officer & GM of Human Resources Department	N/D	N/D	1975
Ms. Jing Li	Executive President and CEO of Established Medicines Manufacturing & Supply Division	N/D	N/D	1972
Mr. Wang Xingli M.D., Ph.D.	Executive President, Co-CEO of Innovative Medicines Division and CEO of Global R&D Center	N/D	N/D	1962
Mr. Wenjie Zhang	Executive President & Co-CEO of Innovative Drug Division	N/D	N/D	1967
Ms. Xiaolei Wu	VP & CFO	N/D	N/D	1980

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Governance aziendale

L'ISS Governance QualityScore di Shanghai Fosun Pharmaceutical (Group) Co., Ltd. al 1 giugno 2024 è 6. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 7; diritti degli azionisti: 10; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.